Viewing Study NCT03218800


Ignite Creation Date: 2025-12-26 @ 12:18 PM
Ignite Modification Date: 2026-01-01 @ 1:23 AM
Study NCT ID: NCT03218800
Status: TERMINATED
Last Update Posted: 2022-08-11
First Post: 2017-07-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ertapenem Administered Subcutaneously Versus Intravenously
Sponsor: Instituto Nacional de Cancer, Brazil
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module